|
Volumn 4, Issue 5, 2004, Pages 425-427
|
Anticancer agents: Towards the future
|
Author keywords
Drug specificity; Telomerase; Topoisomerase; Tyrosine kinase
|
Indexed keywords
ACRIDINE DERIVATIVE;
ANTINEOPLASTIC AGENT;
ANTISENSE OLIGONUCLEOTIDE;
CAMPTOTHECIN;
DNA TOPOISOMERASE;
DNA TOPOISOMERASE INHIBITOR;
ERLOTINIB;
GEFITINIB;
IMATINIB;
PROTEIN TYROSINE KINASE;
PROTEIN TYROSINE KINASE INHIBITOR;
TELOMERASE INHIBITOR;
TELOMESTATIN;
UNCLASSIFIED DRUG;
APOPTOSIS;
CANCER CELL;
CYTOTOXICITY;
DNA REPLICATION;
DNA TRANSCRIPTION;
DRUG EFFICACY;
DRUG MECHANISM;
DRUG TARGETING;
ENZYME ACTIVITY;
ENZYME INHIBITION;
GENETIC CODE;
HUMAN;
REVIEW;
TRANSCRIPTION REGULATION;
ANTINEOPLASTIC AGENTS;
DNA;
DNA TOPOISOMERASES, TYPE I;
DRUG DESIGN;
ENZYME INHIBITORS;
HUMANS;
NEOPLASMS;
OLIGONUCLEOTIDES, ANTISENSE;
PROTEIN-TYROSINE KINASES;
TELOMERASE;
|
EID: 4444313424
PISSN: 15680118
EISSN: None
Source Type: Journal
DOI: 10.2174/1568011043352731 Document Type: Review |
Times cited : (6)
|
References (15)
|